Evidence map›Paper›PMID 35587373›Full record

ArticleJCI insight2022

STAT1 signaling protects self-reactive T cells from control by innate cells during neuroinflammation.

Carlos A Arbelaez, Pushpalatha Palle, Jonathan Charaix, Estelle Bettelli

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 12 citations in OpenAlex.

  1. Adipocyte-derived LTB4 programs human NKG2AJournal for immunotherapy of cancer · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Carlos A ArbelaezCenter for Fundamental Immunology, Benaroya Research Institute at Virginia Mason, Seattle, Washington, USA.
Pushpalatha PalleCenter for Fundamental Immunology, Benaroya Research Institute at Virginia Mason, Seattle, Washington, USA.
Jonathan CharaixCenter for Fundamental Immunology, Benaroya Research Institute at Virginia Mason, Seattle, Washington, USA.
Estelle BettelliCenter for Fundamental Immunology, Benaroya Research Institute at Virginia Mason, Seattle, Washington, USA.
Virginia Mason Medical Center · US

Funding

Regulation of pathogenic T cells in EAER01AI129548 · NIAID · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI BETTELLI, ESTELLE · 2017 to 2021
$2.1M
NIAID NIH HHS R01 AI129548
6 · The paper itself

Abstract

The transcription factor STAT1 plays a critical role in modulating the differentiation of CD4+ T cells producing IL-17 and GM-CSF, which promote the development of experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis (MS). The protective role of STAT1 in MS and EAE has been largely attributed to its ability to limit pathogenic Th cells and promote Tregs. Using mice with selective deletion of STAT1 in T cells (STAT1CD4-Cre), we identified a potentially novel mechanism by which STAT1 regulates neuroinflammation independently of Foxp3+ Tregs. STAT1-deficient effector T cells became the target of NK cell-mediated killing, limiting their capacity to induce EAE. STAT1-deficient T cells promoted their own killing by producing more IL-2 that, in return, activated NK cells. Elimination of NK cells restored EAE susceptibility in STAT1CD4-Cre mice. Therefore, our study suggests that the STAT1 pathway can be manipulated to limit autoreactive T cells during autoimmunity directed against the CNS.

Indexed as

Encephalomyelitis, Autoimmune, ExperimentalMultiple SclerosisAnimalsAutoimmunityCD4-Positive T-LymphocytesMiceNeuroinflammatory DiseasesSTAT1 Transcription FactorStat1 protein, mouseSTAT1 Transcription FactorAutoimmunityCytokinesMultiple sclerosisT cells

Identifiers

PMID35587373
PMCPMC9309063
OpenAlexW4280591870

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.